Analogously, effective suppression of tumour cell growth by YM155 has been described before for MLPS cells sharing strong nuclear aggregations of survivin as the administration of YM155 resulted in a 70–90% decrease of viable cells in two of three cell lines assessed (de Graaff et al. 2017). Here, BIRC5 is linked to neoplasm.